Incanthera (AQSE:INC) EV-to-Revenue : (As of Jun. 21, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Incanthera's enterprise value is £14.99 Mil. Incanthera's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00 Mil. Therefore, Incanthera's EV-to-Revenue for today is .

The historical rank and industry rank for Incanthera's EV-to-Revenue or its related term are showing as below:

AQSE:INC's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.54
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Incanthera's stock price is £0.255. Incanthera's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00. Therefore, Incanthera's PS Ratio for today is .

Incanthera EV-to-Revenue Historical Data

The historical data trend for Incanthera's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera EV-to-Revenue Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Incanthera's EV-to-Revenue

For the Biotechnology subindustry, Incanthera's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Incanthera's EV-to-Revenue falls into.

Incanthera EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Incanthera's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	14.986	/	0
	=

Incanthera's current Enterprise Value is £14.99 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Incanthera's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00 Mil.

Incanthera (AQSE:INC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Incanthera's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.255	/	0
	=

Incanthera's share price for today is £0.255.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was £0.00.

Incanthera EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Incanthera's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines